SCHEMBL22717032

SCHEMBL22717032

COc1ccc2c3c(cccc13)C(=O)N(NCCCN(C)C)C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT1 Q99873 1/20 0.55
▸ KMT2A Q03164 9/20 0.54
▸ POLB P06746 5/20 0.54
▸ LMNA P02545 5/20 0.54
▸ ALDH1A1 P00352 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ PABPC1 P11940 3/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ HTT P42858 2/20 0.54
▸ XBP1 P17861 1/20 0.54
▸ NFKB1 P19838 1/20 0.54
▸ SMARCA2 P51531 1/20 0.54
▸ NFKB2 Q00653 1/20 0.54
▸ RELA Q04206 1/20 0.54
▸ MEN1 O00255 7/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ USP2 O75604 3/20 0.46
▸ HDAC3 O15379 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11718139 0.87 PRMT1 (0.59) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11715772 0.85 KMT2A (0.63) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11715825 0.84 PRMT1 (0.62) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11699932 0.82 LMNA (0.70) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11712854 0.81 PRMT1 (0.65) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11717115 0.81 PRMT1 (0.58) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL28711296 0.79 PRMT1 (0.66) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11717142 0.77 PRMT1 (0.70) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11716330 0.76 KMT2A (0.48) PRMT1KMT2APOLBLMNAALDH1A1
SCHEMBL11712730 0.76 KMT2A (0.48) PRMT1KMT2APOLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220227648-A1 METHOD OF CONTROLLING CARBONATE SCALE IN AQUEOUS SYSTEMS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2022-07-21 — — US disclosed
US-20220119293-A1 METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2022-04-21 — — US disclosed
EP-3977104-A1 METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS Nouryon Chemicals International B.V. (NL) 2022-04-06 — — EP disclosed
US-11208408-B2 Method of controlling scale in aqueous systems NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2021-12-28 — — US disclosed
US-20210253461-A1 METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2021-08-19 — — US disclosed
WO-2020243176-A1 METHOD OF CONTROLLING SCALE IN AQUEOUS SYSTEMS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2020-12-03 — — WO disclosed
WO-2020243180-A1 METHOD OF CONTROLLING CARBONATE SCALE IN AQUEOUS SYSTEMS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2020-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11208408-B2 Method of controlling scale in aqueous systems FGB, F2, F10 PRMT1 3633/4885KMT2A 3747/4885POLB 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback